Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan He

Showing results (671-680 of 704) with videos related to

Pageof 71
Sort By:
Cellular & Molecular Immunology|April 3, 2020
Junctional and somatic hypermutation-induced CX<sub>4</sub>C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibodyChunyan Yi, Jing Xia, Lan He, et al.
Clinical Rheumatology|June 8, 2022
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trialJia Li, Zhixin Xue, Zhenbiao Wu, et al.
Nature Communications|July 19, 2012
Self-assembling subnanometer pores with unusual mass-transport propertiesXibin Zhou, Guande Liu, Kazuhiro Yamato, et al.
Cellular & Molecular Immunology|January 11, 2012
Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapyJuan Zhao, Ji-Yuan Zhang, Hong-Wei Yu, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trialJiuliang Zhao, Changsong Lin, Qibing Xie, et al.
Acta Pharmacologica Sinica|February 4, 2014
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidationLi Yang, Li-ping Shi, Hai-jun Chen, et al.
Journal of Medical Virology|July 14, 2023
Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?Jun He, Qingmin Mei, Yousong Peng, et al.
Journal of Affective Disorders|December 10, 2024
Multidimensional stress and self-harm in Chinese preadolescents: A cross-sectional studyMing Ai, Wo Wang, Jian-Mei Chen, et al.
Cell|September 7, 2024
TGF-β and RAS jointly unmask primed enhancers to drive metastasisJun Ho Lee, Francisco J Sánchez-Rivera, Lan He, et al.
Journal of Medical Virology|July 7, 2021
Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemicJun-Ling Yu, Sai Hou, Ya-Ting Feng, et al.
Pageof 71

Showing results (671-680 of 704) with videos related to

Sort By:
Pageof 71
Cellular & Molecular Immunology|April 3, 2020
Junctional and somatic hypermutation-induced CX<sub>4</sub>C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibodyChunyan Yi, Jing Xia, Lan He, et al.
Clinical Rheumatology|June 8, 2022
Comparison of the efficacy and safety of the adalimumab biosimilar TQ-Z2301 and adalimumab for the treatment of Chinese patients with active ankylosing spondylitis: a multi-center, randomized, double-blind, phase III clinical trialJia Li, Zhixin Xue, Zhenbiao Wu, et al.
Nature Communications|July 19, 2012
Self-assembling subnanometer pores with unusual mass-transport propertiesXibin Zhou, Guande Liu, Kazuhiro Yamato, et al.
Cellular & Molecular Immunology|January 11, 2012
Improved survival ratios correlate with myeloid dendritic cell restoration in acute-on-chronic liver failure patients receiving methylprednisolone therapyJuan Zhao, Ji-Yuan Zhang, Hong-Wei Yu, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trialJiuliang Zhao, Changsong Lin, Qibing Xie, et al.
Acta Pharmacologica Sinica|February 4, 2014
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidationLi Yang, Li-ping Shi, Hai-jun Chen, et al.
Journal of Medical Virology|July 14, 2023
Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?Jun He, Qingmin Mei, Yousong Peng, et al.
Journal of Affective Disorders|December 10, 2024
Multidimensional stress and self-harm in Chinese preadolescents: A cross-sectional studyMing Ai, Wo Wang, Jian-Mei Chen, et al.
Cell|September 7, 2024
TGF-β and RAS jointly unmask primed enhancers to drive metastasisJun Ho Lee, Francisco J Sánchez-Rivera, Lan He, et al.
Journal of Medical Virology|July 7, 2021
Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemicJun-Ling Yu, Sai Hou, Ya-Ting Feng, et al.
Pageof 71